COYA

Coya Therapeutics, Inc.

• PUBT·7h ago

  Coya Therapeutics to present Phase 2 ALSTARS trial design for COYA 302 in ALS at June summit

• PUBT·7h ago

  Coya Therapeutics presents ALSTARS Phase 2 trial design at ALS Drug Development Summit

• TipRanks·5d ago

  Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)

• TipRanks·05/13 14:37

  Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street

• PUBT·05/13 12:31

  Coya Therapeutics announces annual shareholder meeting

• TipRanks·05/13 10:40

  Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Palisade Bio (PALI)

• TipRanks·05/13 04:30

  Analysts Are Bullish on These Healthcare Stocks: Coya Therapeutics, Inc. (COYA), Sagimet Biosciences, Inc. Class A (SGMT)

• TipRanks·05/12 14:07

  Coya Therapeutics Establishes $30 Million ATM Equity Program

• Benzinga·05/12 12:52

  Coya Therapeutics Launches $30M At-The-Market Stock Offering Agreement With Leerink Partners

• Reuters·05/12 12:50

  COYA THERAPEUTICS: ENTERED INTO SALES AGREEMENT, MAY OFFER AND SELL FROM TIME TO TIME SHARES OF CO'S COMMON STOCK FOR UP TO $30 MLN

• PUBT·05/12 12:49

  Coya Therapeutics enters at-the-market equity sales agreement for up to $30 million stock offering

• TipRanks·05/12 12:37

  Coya Therapeutics Updates Q1 Results, COYA 302 Progress

• Seeking Alpha·05/12 12:24

  Coya Therapeutics GAAP EPS of -$0.32, revenue of $251.1M

• NASDAQ·05/12 12:04

  Coya Therapeutics: COYA 302 Receives FDA Fast Track Designation For Treatment Of ALS

• TipRanks·05/12 11:54

  Coya Therapeutics granted FDA Fast Track Designation for COYA 302